Technical Information

 

“Canine joint therapy with Synovetin OA™ has early disease-modifying effects by breaking the inflammatory cycle associated with synovitis” Technical Bulletin

“Canine joint therapy with Synovetin OA™ has early disease-modifying effects by breaking the inflammatory cycle associated with synovitis” Technical Bulletin

“Radiosynoviorthesis: A new therapeutic and diagnostic tool for canine joint inflammation” Technical Bulletin

“Radiosynoviorthesis: A new therapeutic and diagnostic tool for canine joint inflammation” Technical Bulletin

“Safety and effectiveness of Synovetin OA™: Results of three randomized trials evaluating treatment of naturally occurring canine elbow osteoarthritis” Technical Bulletin

“Safety and effectiveness of Synovetin OA™: Results of three randomized trials evaluating treatment of naturally occurring canine elbow osteoarthritis” Technical Bulletin

RAM Navigator Program Brochure

Exubrion Therapeutics Corporate Overview

Synovetin OA™ Product Overview

Synovetin OA™ Product Overview

Inflammatory Cycle

Inflammatory Cycle

Assessment of Canine Elbow Joint for Osteoarthritis

Assessment of Canine Elbow Joint for Osteoarthritis

RAM Navigator

RAM Navigator Program Brochure

Tin-117m Spec Sheet

Tin-117m Spec Sheet

Synovetin OA® delivers sustained OA pain relief.1

Learn about once-yearly treatment

Synovetin OA® provides targeted, non-systemic therapy.2

Review the safety data

References:

  1. Data on file, Exubrion Therapeutics.
  2. Donecker JM, Fox SM. Safety and effectiveness of Synovetin OA™: Results of three randomized trials evaluating treatment of naturally occurring canine elbow osteoarthritis. Exubrion Therapeutics, July 2019.